Intermittent Fasting: What the Evidence Actually Shows

What Is Intermittent Fasting?

Intermittent fasting (IF) is not a diet in the conventional sense — it is a pattern of eating that cycles between periods of eating and fasting. Rather than restricting what you eat, IF focuses on when you eat. The biological rationale is that during fasting periods, insulin levels fall, glycogen stores deplete, and the body shifts toward fat oxidation and cellular repair processes (particularly autophagy — the cellular "self-cleaning" mechanism).

Several IF protocols have been studied:

• 16:8 (time-restricted eating) — eating within an 8-hour window daily; most popular and studied
• 18:6 or 20:4 — narrower eating windows
• 5:2 — eating normally 5 days, restricting to 500–600 kcal on 2 non-consecutive days
• Alternate-day fasting (ADF) — alternating normal eating days with near-complete fasting
• Prolonged fasting — 24–72+ hours; less studied for routine use, higher risk

Weight Loss: How Does IF Compare to Continuous Calorie Restriction?

The most important finding from rigorous trials is that IF produces weight loss roughly equivalent to continuous calorie restriction — not significantly better. A 2020 JAMA Internal Medicine RCT (the TREAT trial) randomised 116 participants to 16:8 TRE or unrestricted eating for 12 weeks. The TRE group lost 0.94 kg vs 0.68 kg in controls — not statistically significant.

Meta-analyses of multiple trials consistently show:

• IF produces 0.8–13% body weight loss, similar to equivalent calorie restriction
• No evidence of superior fat loss when protein intake and overall calories are matched
• Adherence and dropout rates are comparable between IF and conventional diets

The practical appeal of IF is that some people find it easier to restrict calories by limiting their eating window than by continuously monitoring intake.

Metabolic Effects Beyond Weight

Several metabolic improvements have been documented in IF trials, some independent of weight loss:

• Insulin sensitivity — fasting lowers fasting insulin and improves HOMA-IR; particularly relevant for insulin-resistant individuals and type 2 diabetes prevention
• Fasting glucose — modest reductions, most significant in people with elevated baseline glucose
• Triglycerides — consistently reduced by IF protocols; one of the more robust findings
• Blood pressure — a 10-hour eating window reduced systolic BP by ~3 mmHg in a metabolic syndrome cohort (Wilkinson et al.)
• LDL cholesterol — inconsistent findings across studies; some trials show reduction, others no change
• Inflammation markers (CRP, IL-6) — modest reductions in some but not all studies

Autophagy and Longevity: Promising but Unproven in Humans

Autophagy — cellular recycling of damaged proteins and organelles — increases during fasting. This mechanism underlies much of the anti-aging and cancer-prevention interest in IF. Evidence from animal models is compelling: caloric restriction and IF extend lifespan in yeast, worms, flies, and rodents by 30–50%.

However, direct evidence in humans remains limited. No long-term human RCT has demonstrated that IF extends lifespan or reduces cancer incidence. The CALERIE trial showed that 25% calorie restriction over 2 years improved several biomarkers of longevity in humans, but outcomes like mortality will take decades to measure.

A 2024 Cardiovascular Caution

A 2024 preliminary American Heart Association report (presented, not yet peer-reviewed) found an association between 8-hour time-restricted eating and a 91% higher risk of cardiovascular death in a large observational analysis. Importantly, this was a correlation — not a controlled trial — and the TRE group may have already had poorer health. This finding requires cautious interpretation but should not be ignored, particularly for people with existing cardiovascular disease.

Who May Benefit

• People who prefer meal skipping over calorie counting as a weight management strategy
• Adults with insulin resistance or pre-diabetes who struggle with conventional diets
• People who naturally eat within a shorter window without feeling deprived

Who Should Be Cautious or Avoid IF

• Pregnancy and breastfeeding — caloric restriction is contraindicated
• History of eating disorders — restrictive patterns can trigger relapse
• Type 1 diabetes or insulin-dependent type 2 diabetes — hypoglycaemia risk; requires medical supervision if attempted
• Underweight individuals
• Children and adolescents
• Those on certain medications (anticoagulants, lithium) requiring consistent food intake

Practical Approach

If you choose to try IF, earlier eating windows (e.g. 8am–4pm or 10am–6pm) appear to be more metabolically beneficial than late eating windows based on circadian rhythm research. Ensure protein intake ≥1.2 g/kg/day to minimise lean mass loss. IF does not justify poor food quality — food choices within the eating window still matter substantially.